Lot Release Number |
2019-05-21-0103
|
FDA Registered Product/Generic Name |
Combined Diphtheria, Tetanus and Acellular Pertussis, Hepatitis B, Inactivated Poliomyelitis and Haemophilus influenzae Type B Vaccine (Preservative-free)
|
Brand Name |
Infanrix Hexa
|
Dosage Strength |
0.5 mL
|
Dosage Form |
Suspension for Injection (I.M.)
|
Registration Number |
BR-508
|
Batch/Lot Number |
A21CD487B (DTPa-HBV-IPV: AC21B717A; HiB: AHIBD332B)
|
Packaging Lot |
Packaging lot (box): A21CD487B
Pre-filled syringe: A21LD487B, MD 05-2018, ED 04-2021 Vial: A21FD487B, MD 03-2018, ED 02-2021;
Needles (25G x 1"): 181005, ED 2023-09-30
|
Product Expiration Date |
28 February 2021
|
Issuance Date |
23 May 2019
|